Which childhood vaccines are no longer routinely recommended in the US and why it matters

Which childhood vaccines are no longer routinely recommended in the US and why it matters

• US narrows childhood vaccine guidance, making several shots optional or targeted
• Flu, rotavirus, meningitis vaccines now optional based on parental or risk discretion
• Experts warn changes may lower vaccination rates and increase disease outbreaks

Did our AI summary help?

The federal government in the US has quietly but significantly rewritten the childhood vaccination playbook. Under the Trump administration and Health Secretary Robert F. Kennedy Jr., several vaccines that were once routinely recommended for all children are now subject to narrower guidance.

US administration officials say the changes are meant to align the United States with countries that recommend fewer shots and to give parents greater flexibility to decide, in consultation with doctors, what is best for their children. Public health experts and medical associations counter that the revisions risk lowering vaccination rates and increasing outbreaks of preventable diseases, the Washington Post reported.

Flu shots move from routine to optional

Annual influenza shots are no longer broadly recommended for all children. Instead, parents are now advised to decide in consultation with medical professionals.

Health officials note that flu-related deaths primarily affect older adults. But paediatricians point out that last year’s unusually severe flu season led to nearly 300 deaths among children, most of whom were unvaccinated. Young children remain especially vulnerable to serious complications from influenza.

Vaccination rates are already low, with fewer than half of US children receiving a flu shot in the most recent season. Critics argue that removing routine recommendations could push uptake even lower.

Hepatitis A and B guidance narrowed

The Centers for Disease Control and Prevention no longer recommends hepatitis A vaccination for all children between 12 and 23 months. Instead, it is advised mainly for children traveling to countries where the virus is common.

Hepatitis A infections in the US dropped by more than 95 percent after widespread vaccination began in the 1990s. The administration now argues the disease is rare and that the benefit-risk ratio for most children is low.

Hepatitis B guidance has also changed. Infants born to mothers who test negative for the virus may now delay or potentially skip early doses, following medical advice. Paediatric experts warn that universal vaccination helped prevent cases caused by testing errors or early exposure.

Meningitis vaccines limited to high-risk groups

Meningococcal vaccines, which protect against bacterial meningitis, are no longer routinely recommended for all adolescents. Instead, they are targeted to higher-risk groups, including children with compromised immune systems, first-year college students living in dormitories and those traveling to countries where the disease is endemic.

Although meningococcal disease is rare, it is deadly in up to 15 percent of cases and can cause lifelong disabilities in survivors.

Rotavirus left to parental discretion

Rotavirus vaccines, once routinely given to infants, are now optional. Before vaccination became widespread, the virus hospitalized tens of thousands of US children each year and caused dozens of deaths.

Federal officials say severe outcomes are now uncommon and that parents should decide with their doctors. Paediatric infectious-disease specialists strongly disagree, noting that rotavirus causes rapid dehydration that can be difficult to manage at home.

HPV dosing reduced, despite debate

The administration continues to recommend vaccination against human papillomavirus, but now advises a single dose instead of two. The decision follows global guidance from the World Health Organization, which has endorsed one-dose regimens to expand coverage worldwide.

However, the Food and Drug Administration has told vaccine maker Merck that evidence is insufficient to confirm that one dose offers the same long-term cancer protection as two. Critics fear insurers may stop covering a second dose, limiting options for families.

RSV guidance sparks confusion

Guidance for protection against respiratory syncytial virus, a leading cause of infant hospitalisation, has not substantively changed. Maternal vaccination or monoclonal antibodies remain recommended, particularly for high-risk infants.

Mixed messaging from federal officials, however, has led to widespread confusion among parents and clinicians about who qualifies for protection.

Why doctors are alarmed

Public health experts in the US say the cumulative effect of these changes could be fewer vaccinated children, more parental uncertainty and a higher risk of outbreaks. They argue that routine recommendations simplify access, improve insurance coverage and protect children who might otherwise be missed.

Administration officials see the changes as restoring parental autonomy. Critics see them as a retreat from decades of evidence-based policy.

What is clear is that the burden of decision-making has shifted sharply onto parents and physicians, at a time when trust, clarity and consistency in public health guidance are already under strain.